Owing to benefits such as generation of precise diagnostic results, a substantial reduction in human errors, live streaming of images, whole slide imaging (WSI), enhanced imaging, improved analysis, accurate and quicker evaluation as opposed to conventional microscopy, the global Digital Pathology Market is witnessing enormous growth and adoption

It’s being expected that by 2030, the Digital Pathology market cap will hit USD 1.74 billion at a CAGR growth of about 7.5%. 

Covid-19 Impact & Market Status

Whilst covid-19 pandemic has adversely affected the markets around the world including global digital pathology market, at the same time the pandemic has also given boost to the global digital pathology market. Digital pathology proved advantageous during the pandemic it was possible to work remotely. Also, digital pathology allowed group consultation to be carried out without face-to-face contact, required no physical slide, and enabled quicker access to results and evaluation especially in cases that require instant sampling like cancer for further processes.

This report offers comprehensive study of the market. The information and insightful data about the market provided in the report helps the market participants address the risks systematically and make well-informed decisions. Moreover, the report determines the market structure of global Data Preparation Tools market. The report analysts have included the suggestions and comments from the global Data Preparation Tools market experts and professionals to document the report.

Artificial Intelligence Embedded Digital Pathology Segment is the Most Attractive Segment

The global Digital Pathology market is classified into data storage, software, scanner, and artificial intelligence on the basis of product. Among these, the artificial intelligence segment secured the top-most position in terms of revenue in the global Digital Pathology market and is poised for substantial growth in future. The artificial intelligence segment  embedded digital pathology provides faster/efficient and more accurate measurements, exact quantification of tumor cell content for molecular analyses, enhanced image features, and other benefits. Thus it has increased the demand for digital pathology becoming the largest revenue holder segment in global digital pathology market.

Telepathology Segment to Remain Atop

The global Digital Pathology market is classified into clinical (telepathology, archiving, image analysis) nonclinical (education, testing, research on the basis of applications. Among these, the telepathology segment held the largest market share in global Digital Pathology market and has witnessed more demand due to factors such as possible quicker access, no need of physical slide transfer, lower threshold for consultation due to shorter turnaround time.

Pharmaceutical Companies to Ensure Revenue Maximization

The global Digital Pathology market is classified into pharmaceutical companies and hospitals on the basis of end user. Among these, the pharmaceutical companies secured the highest position in the global Digital Pathology market in terms of revenue, market share, and CAGR. Digital pathology adoption is extensive in pharmaceutical companies for faster and accurate image evaluation like for reducing cancer care lead time. Furthermore, the pharmaceutical companies are adopting Digital Pathology for drug discovery and development which is helping them manage and analyze millions of samples whilst maintaining costs and getting more time to develop viable drug candidate. These are key factors that have increased the demand of digital pathology in pharmaceutical companies.

North American Region to Witness Huge Investments

North America is the most mature markets in the global Digital Pathology market due to rising burden of rising prevalence of cancer, growing application of digital pathology in drug discovery and development, relaxation in in certain guidelines by federal government leasing to faster adoption of digital pathology, presence of digital pathology firms in countries like US and Canada such as XIFIN, Corista, Apollo Enterprise Imaging, Leica Biosystems, and others. 

The need for accurate and quicker clinical diagnosis, the need to reduce cancer care lead time, cost savings, standardization of laboratory procedures, and all pre-analytical processes has identified digital pathology as the best option, boosting the growth outlook for the global Digital Pathology Market

Rapid applications of digital pathology in all the clinical (clinical (telepathology, archiving, image analysis) and nonclinical (education, testing, research) applications are fostering progress in global digital pathology market. Advantages such as the superlative capability to measure binary or categorical features with a higher degree of precision and reproducibility, high performance across multiple clinical and non-clinical processes encourage further adoption of digital pathology. 

Digital pathology is an image-based information environment enabled by computer technology that allows for the management of information generated from a digital slide. The unique feature of digital pathology is that it maximizes the practical utility of the captured images and allows its further use for storage, viewing, annotation, and use of the images in applications including educational, research, and clinical practices.

Factors such as the growth of digital pathology and faster whole slide image scanning in recent years are paving the way for the development of the global digital pathology market.

However, technology limitations, regulatory obstacles, significant equipment cost, difficulties implementing digital pathology, and pathologist technophobia are several barriers to the adoption of digital pathology likely to hamper the global digital pathology market. Nevertheless, digital pathology is expected to become increasingly vital for the future of pathology practice expected to give a boost to the global digital pathology market. Also, the emergence of useful tools and techniques in digital pathology arena providing toxicologic pathologists with some unique and outstanding tools saving evaluation time, more quantifiable data relevant to risk assessment activities are accelerating the adoption of digital pathology anticipated to be key growth opportunity to the global digital pathology market.

The major players in global Digital Pathology market are Roche, Kanteron Systems, Proscia, Mikroscan Technologies, Inspirata, KONFOONG BIOTECH INTERNATIONAL, Glencoe Software, OptraSCAN, Objective Pathology Services, Indica Labs, Corista, Visiopharm A/S, Huron Digital Pathology, XIFIN, Apollo Enterprise Imaging, 3DHISTECH, Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems among others. The above-mentioned companies have coined great progress in coining new technologies for digital pathology. These firms are dominating the global digital pathology market through innovative research and development in the field of digital pathology.

Latest Innovations in the Global Digital Pathology Market: a Snapshot

• Leica Biosystems, Germany the medical devices company launched the Aperio GT 450. Aperio GT 450, the brightfield whole slide scanner allows histotechnicians to complete scanning tasks quickly. The scanning speed of the scanner is as small as 32-seconds.
• F. Hoffmann-La Roche Ltd, the Switzerland based multinational healthcare company launched uPath enterprise software. Performance and productivity quotient of digital pathology is improved by the newly launched, uPath.

Digital Pathology Market Scope

Key Segments of the Global Digital Pathology Market

Product Overview, (USD Billion)

• Data storage
• Software
• Scanner
• Artificial intelligence

Applications Overview, (USD Billion)

• Clinical
  • Telepathology
  • Archiving
  • Image analysis
• Non-clinical
  • Education
  • Testing
  • Research

End User Overview, (USD Billion)

• Pharmaceutical
• Companies
• Hospitals

Regional Overview, (USD Billion)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• Rest of Asia Pacific

South America

• Mexico
• Brazil
• Rest of South America

Middle East and South Africa